Company / R&D per Share
RHYTHM PHARMACEUTICALS, INC. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.68
FY2025
5-year range
$2.08 / $4.00
FY2021-FY2025
Trend
-33.0%
vs FY2024
Sector context
#79 of 208
Health Care
What the data says
At $2.68, RHYTHM PHARMACEUTICALS, INC.'s r&d per share ranks #79 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $1.84 in FY2018 to $4.00 in FY2024.
Based on SEC 10-K filings.
2.68 in FY2025 with a 5-year CAGR of +5.5%.
Improved from $2.38 to $2.68 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- +5.5%
- 10-Year CAGR
- -
Sector benchmark
#79 of 208 in Health CareTop 38% of 208This company $2.68 Sector average $28.82
▼
-90.7% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 33.0% year-over-year.
- Ranks #79 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.68 | -33.0% |
| FY2024 | $4.00 | +68.0% |
| FY2023 | $2.38 | +14.4% |
| FY2022 | $2.08 | -0.7% |
| FY2021 | $2.10 | +2.4% |
| FY2020 | $2.05 | -31.8% |
| FY2019 | $3.01 | +62.9% |
| FY2018 | $1.84 | -17.8% |
| FY2017 | $2.25 | +16.8% |
| FY2016 | $1.92 | +174.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026